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Abstract 
Layered double hydroxides (LDH) have many applications as matrices in pharmaceutical fields. -Indomethacin is a non-
steroidal anti-inflammatory drug (NSAID) and the salt Sodium Indomethacin (INDONa) have been used as host drugs to 
be intercalated into LDH. As consequence of salt formation a polymorph of indomethacin was obtained. Intercalated 
compound was prepared via ion exchange and co-precipitation. As consequence of the intercalation, the interlayer 
distance of the host increased. The NSAID and LDH-INDONa were characterized by XRD, FT-IR and drug content was 
determinate by UV spectroscopy. The highest percentage of INDONa load was observed in the LDH-CI incorporated by 
direct method (48.40 wt%). 
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1. Introduction 
Recently, there has been rapid expansion of the development of bioinorganic hybrid systems for safe drug 
delivery. Bioinorganic systems can allow safe and controlled delivery of various bioagents into targets with 
high efficiency. Hybrid systems for drug delivery require biocompatible inorganic matrices that permit safe 
retention as well as controlled delivery of drugs, (Choy et. al., 2004). Between a varieties of inorganic 
materials, layered double hydroxides (LDHs) are amongst attractive materials for the preparation of a 
controlled drug release formulation. 
Layered double hydroxides or hydrotalcite-like compounds are a family of natural or synthetic materials 
with a formulation of [M2+1 xM3+ x(OH)2][An x/n 2O], where M2+ and M3+ are, respectively divalent and 
trivalent metals, and An  is the intercalated hydrated counter-anion. These materials form successive positively 
charged layers, compensated by intercalation of hydrated negatively charged species. LDH has a structure 
similar to that of brucite (the common name for magnesium hydroxide, with a basal distance of 4.8 Å) and 
their interlayer distance depends on the size of the intercalated hydrated anion. 
A variety of anionic species could be intercalated for the formation of LDH-intercalated or the so-called the 
host-guest type materials. The guest species enhance the interlayer distance in the LDH compounds and the 
thickness of the layer is determined by the ionic radius of the anion. If the anion is of a beneficial agents such 
as drugs or herbicides and by virtue of the ion-exchange properties of LDH, then this type of materials can be 
exploited as controlled release formulation. For example, Ambrogi et. al., 2001 have reported intercalation of 
an anti-inflammatory drug such as ibuprofen between LDH is aimed to give a formulation with controlled 
release capability and Jubri et. al., 2008 have reported about intercalation of pamoate anion. 
Indomethacin is a member of the non steroidal anti-inflammatory drugs (NSAID). It is used to reduce pain 
involved in osteoarthritis, rheumatoid arthritis, bursitis, gout, etc. (Sweetman, 2005), however, are well known 
side effects including gastrointestinal disturbance. The drug is described as poorly soluble and highly 
permeable (class II) drug. Because water-insoluble drugs often show low absorption and weak bioavailability, 
improvement in dissolution rate and/or solubility are important for development of drug preparations. The 
successful formulation of poorly water-soluble drugs is one of the major of problems in pharmaceutical 
- -form. From a 
biopharmaceutical point of view and for active ingredients of low solubility, the dissolution rate of each 
polymorph is a limiting factor in absorption processes. Solubility in each case will depend upon the reticular 
energies of the crystalline edifice, as well as the varying enthalpy and fusion points that they present. 
Ambrogi et al., 2003, proposed that after the intercalation and release of non steroidal anti-inflammatory 
drugs (NSAID) which are aromatic organic compounds with easily ionizable carboxylate groups, the apparent 
drug solubility increases. For instance, it was reported that the dissolution rates of some sodium salts are 
several orders of magnitude greater than the weak-acid counterparts (Chen et. al., 2005). 
This paper reports studies on preparation and characterization of an intercalation compound of nanosized 
MgAl hydrotalcite-type material containing the anionic form of indomethacin in the interlayer region, starting 
from sodium indomethacin (INDONa). The samples have been prepared by anion exchange and direct co-
precipitation procedure and characterized by different physicochemical techniques to choose the optimum 
experimental conditions to obtain samples with a high drug loading. 
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2. Experimental 
2.1.  -Indomethacin and Sodium Indomethacin 
- -form in hot ethanol followed by rapid precipitation 
with the quick addition of cold water. Then is carried to refrigerator for 15 min and dried in a rotary 
evaporator at 50 °C and 40 rpm. 
Sodium Indomethacin hydrate was obtained by co-precipitation of Na2CO3 over a s -
Indomethacin, was stirred for 30 min and then dried in an oven at 40-60 °C.  
2.2. Synthesis of the samples  
The synthesis methods for the host solids adopted in this study were by co-precipitation. The synthesis 
conditions are shown in Table 1. The intercalation methods were direct co-precipitation and anion exchange. 
2.2.1.  Intercalation by indirect synthesis: ion exchange 
 Synthesis the host solids: The host solids were prepared by co-precipitation method, at low super 
saturation method at constant pH (10 ± 0.2), with Mg2+/Al3+ = 3 molar ratio constant. Two solutions 
designated A and B, were prepared. In order to obtain A solution, AlCl3.6H2O and MgCl2.6H2O were 
dissolved together in decarbonated and deionized water (H2O dd); while the B solution is NaOH 2 M. Both 
solutions were added simultaneously to 50 mL of H2O dd. The co-precipitation was carried out at room 
temperature under nitrogen atmosphere to avoid the incorporation of CO2. The mixture was kept under 
magnetic stirring for 20 minutes. The product was filtered, and dried for 10 hours at 70ºC. These samples 
were called LDH-S (Short aging time). Similar procedure was followed for preparing other materials, varying 
the time of stirring and aging. In this case, the mixtures were kept under magnetic stirring for 4 hours and 
them they were left in repose for 18 hours. Finally, the host solids were filtered, washed with decarbonated 
water until pH 7, dried for 10 hours at 90ºC. These samples were called LDH-L (Long aging time). 
2.2.2. Intercalation of INDO into LDH-S and LDH-L: 
Intercalation reactions were performed by equilibrating 0.67 g of solid host in 50 mL H2O dd with 50 mL 
of a solution 0.056 M of INDONa; pH = 8 was maintained by addition of 2 mL NaOH 0.1M. This sample was 
put into a bath at 70°C for 3 days under magnetic stirring and nitrogen atmosphere to avoid the incorporation 
of CO2, similar to Ambrogi et al.2002 and Dupin et al. 2004. After cooling, the mixture was filtered in 
vacuum and washed, finally dried at room temperature. These samples were called LDH-SI and LDH-LI. 
 
Table 1: Synthesis Conditions of the host solids. 
 
 
 
 
 
 
Sample Synthesis Conditions 
LDH-S Co-precipitation at room temperature - Aging at room temperature, 20 min  
LDH-L Co-precipitation at room temperature - Aging at room temperature, 4 h, washed until pH=7 
LDH-C Co-precipitation at 35°C - Aging at 60°C, 20 h  
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2.3. Intercalation of INDO by direct synthesis: Co-precipitation 
The co-precipitation method for the direct synthesis of LDH containing the drug was performed by adding 
an aqueous solution of metal chloride salts to an aqueous solution of the drug (INDONa) (Dupin et al. 2004). 
A mixture of AlCl3.6H2O and MgCl2.6H2O was dissolved in 100 mL of H2O dd, with M2+/M3+ = 2 molar ratio 
constant. The aqueous solution was slowly added under magnetic stirring to 50 mL H2O dd with the drug; pH 
= 10 was maintained by the continuous addition of 0.10 M NaOH. The co-precipitation was carried out at 
35°C in nitrogen atmosphere to avoid the incorporation of CO2. The resulting suspension was stirred for 20 h 
at 60 ºC. The product was filtered, washed with decarbonated water at 60 ºC and finally dried at room 
temperature. These samples were called LDH-CI (Co-precipitation method). The sample without drug 
incorporated by direct method was prepared to compare with the other solids host. This sample was called 
LDH-C. 
2.4. Sample characterization 
Powder X-
radiation (  and a scan range between 1,5º and 70º. 
The Fourier-Transform Infrared spectra (FT-IR) of the samples were recorded on a Jasco 5300 using KBr 
pellets with a resolution of 2 and 4 cm-1. Spectra were collected in the region of 4000-400 cm-1. 
For the scanning electron microscopy (SEM) study of the parent LDH, were obtained in a JEOL JSM-6380 
LV. Gold Coverage was applied to make samples conductive. The acceleration voltage was 20 kV. 
Moreover, the solids were analyzed with a JOEL JEM-1200 EX II. A small drop of the dispersion (sample 
in solution water-ethanol 50%) was deposited on copper grid and then evaporated in air at room temperature. 
amount of LDH-INDONa was dissolved in 1M HCl solution under magnetic stirring for 2 h to dissolve the 
LDH matrix and then successive dilution with phosphate buffer at pH 7.4, similar to Berber et. al. 2008. 
3. Results and discussion 
The XRD diagrams for the host solids are shown in Fig. 1. The XRD patterns exhibit the characteristic 
as (Xia et. al. 2008). In the host solids LDH-L and LDH-C a good crystallinity 
was 003
Whereas the host solid LDH- 003 
marked with an asterisk, due to poor washing. The interlayer 
distance, value of d003, representing the summation of thickness of brucite-
height, which is a function of the number, the size and the orientation of intercalated anions. 
Successful intercalation of each anion into the LDH host is demonstrated by the XRD diagrams of the 
materials (Fig 2). During ion exchange of the chlorides anions, the layers of LDH expand to host the anions 
(INDONa) and this expansion is reflected by the values of d003 
-INDONa, which are larger than those for the precursors 
Furthermore, 
the peak approximately at 11.50º in 2  (marked by #) in Fig. 2 correspond to the (003) reflection of LDH, 
while these peaks were overlapped by the (009) reflection of LDH-INDONa. The length of Indomethacin is 
; the interlayer heights can be performed if the drug molecules are arranged in partially 
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Figure 1: XRD patterns of precursors: (a) LDH-S; (b) LDH-L and (c) LDH-C. (* NaCl phase) 
 
 
 
 
 
 
 
Figure 2: XRD patterns of the LDH-INDO intercalation compounds: (a) LDH-SI; (b) LDH-LI and (c) LDH- -INDO phase, # 
overlap phases: (009) LDH-INDO and (003) LDH. 
Table 2: Intercalation method, Interlayer Distance and Drug Content of incorporated products. 
 
 
 
 
 
 
Fig. 3 shows the reference FT- -indomethacin, -indomethacin, and sodium indomethacin 
hydrate. - -indomethacin have distinct absorption bands in the carbonyl region 
because each exhibits different crystal packing and hydrogen bonding. As Chen et. al. 2005 proposed, t -
Indomethacin has characteristic absorption bands at 1717 and 1692 cm 1. The 1717 cm 1 absorption band in 
Sample Intercalation method of INDONa d [Å] INDONa [wt%] 
LDH-CI Direct: Co-precipitation 25.21 48,40 
LDH-SI In direct: Ion exchange 19.39-25.96 7.83 
LDH-LI In direct: Ion exchange 20.24 13.98 
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-indomethacin is assigned to the carbonyl stretch of the carboxylic acid dimer. The 1692 cm 1 absorption 
band is assumed to be the carbonyl stretch of the non- -Indomethacin has 
characteristic absorption bands at 1735, 1692, and 1680 cm 1, which is related to its crystal structure. The 
1692 cm 1 absorption band in both forms is assumed to be the carbonyl stretch of the non protonated amide 
while the absorption band at 1680 cm 1 is assigned to the protonated amide. The absorption band at 1560 cm 1 
in sodium indomethacin trihydrate is assigned to the asymmetric carboxylate stretch. Sodium indomethacin 
hydrate has two other characteristic absorption bands at 3647 and 3538 cm 1 from water hydroxyls, which are 
typical for a hydrate. 
Comparing the spectra of the INDONa and the crystalline drugs (Fig. 3), demonstrating that the INDONa 
-Indomethacin, after the co-precipitation. The Figure 4 shows the 
FT-IR spectra of the host solids intercalated with INDONa.  The region at 1550-1560 cm-1 related with the 
carboxilate group, indicated that the INDONa was intercalated in anionic form.  
 
 
 
 
 
 
 
 
Figure 3: FT- - -Indomethacin and (c) Sodium Indomethacin hydrate. 
 
 
 
 
 
 
 
Figure 4: FT-IR spectra of LDH-INDONa. (a) LDH-SI, (b) LDH-LI and (c) LDH-CI. 
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The morphology and size of LDH-INDONa have been estimated from SEM analyses. In the figure 5 the 
micrographs of the intercalated samples LDH (SI-LI-CI) (a-b-c) are presented. SEM micrographs showed, in 
general, all materials the intercalation products show a layered structure with irregular crystals, except LDH-
CI. In the LDH-LI (Fig 5-a) presents irregular plate-like particles and discontinuous plate-plate stacking with 
breaks and holes was observed. The LDH-SI (Fig. 5-b) displays a greater irregularity and less size particles. 
Fig. 5-c can be seen that the sample consists of relatively uniform hexagonal platelet-like sheets (Pan et. Al. 
2010). 
 
 
 
 
 
 
Figure 5: SEM images of LDH-INDONa: (a) LDH-LI, (b) HDC-SI, (c) LDH-CI  
The amount of INDO was determined by UV-VIS spectrophotometer (Table 2), the loading efficiency 
increases when the drug is directly intercalates into the host solid (direct synthesis). The highest percentage of 
INDONa load was observed in the LDH-CI (48.40 wt%), whereas samples synthesized by ion exchange 
(LDH-SI and LDH-LI) 7.83 wt% and 13.98 wt% respectively were obtained.  
4. Conclusions 
Nanocomposites of Mg/Al layered double hydroxides-INDONa have been synthesized by using direct and 
indirect methods. In all LDH materials the hydrotalcite phase was detected by XRD and a proper crystalline 
structure except when prepared via the co-precipitation method with low time of agitation.  By FT-IR spectra 
revealed - -Indomethacin, when obtained sodium 
indomethacin. This structural change can be provides a higher solubility/dissolution rate. The highest 
percentage of INDONa load was observed in the LDH-CI incorporated by direct method (48.40 wt%). 
Therefore, it could be concluded that LDH is an excellent biocompatible inorganic matrix that could improve 
the controlled release property. 
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